Sickle cell trait and incident ischemic stroke in the atherosclerosis risk in communities study

Stroke

Volumn 45, Issue 10, 2014, Pages 2863-2867

  Caughey, Melissa C ^a,b   Loehr, Laura R ^b   Key, Nigel S ^a   Derebail, Vimal K ^a   Gottesman, Rebecca F ^c   Kshirsagar, Abhijit V ^a   Grove, Megan L ^d   Heiss, Gerardo ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

epidemiology; sickle cell trait; stroke

Indexed keywords

HEMOGLOBIN A;

ADULT; ARTICLE; BLACK PERSON; BRAIN ISCHEMIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SICKLE CELL TRAIT; AFRICAN AMERICAN; AGED; ATHEROSCLEROSIS; COHORT ANALYSIS; COMPLICATION; GENETICS; GENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STROKE;

AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SICKLE CELL TRAIT; STROKE;

EID: 84922481884     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006110     Document Type: Article

References (35)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation. 2012;125:e2-e220.
2. Brown DL, Boden-Albala B, Langa KM, Lisabeth LD, Fair M, Smith MA, et al. Projected costs of ischemic stroke in the United States. Neurology. 2006;67:1390-1395.
3. Golomb MR. Sickle cell trait is a risk factor for early stroke. Arch Neurol. 2005;62:1778-1779.
4. Dowling MM. Sickle cell trait is not a risk factor for stroke. Arch Neurol. 2005;62:1780-1781.
5. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13:501-512.
6. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
7. Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110:908-912.
8. Greenberg J, Massey EW. Cerebral infarction in sickle cell trait. Ann Neurol. 1985;18:354-355.
9. Radhakrishnan K, Thacker AK, Maloo JC, el-Mangoush MA. Sickle cell trait and stroke in the young adult. Postgrad Med J. 1990;66:1078-1080.
10. Riggs JE, Ketonen LM, Wang DD, Valanne LK. Cerebral infarction in a child with sickle cell trait. J Child Neurol. 1995;10:253-254.
11. Gines R, Truemper E. Stroke in a 9-year-old with sickle cell trait. Am J Emerg Med. 1998;16:104-105.
12. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol. 1996;49:1441-1446.
13. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, et al. Best practices and joint calling of the HumanExome BeadChip: The CHARGE Consortium. PLoS One. 2013;8:e68095.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: A tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet. 2007;81:559-575.
15. Toole JF, Lefkowitz DS, Chambless LE, Wijnberg L, Paton CC, Heiss G. Self-reported transient ischemic attack and stroke symptoms: methods and baseline prevalence. The ARIC Study, 1987-1989. Am J Epidemiol. 1996;144:849-856.
16. Karanjia PN, Nelson JJ, Lefkowitz DS, Dick AR, Toole JF, Chambless LE, et al. Validation of the ACAS TIA/stroke algorithm. Neurology. 1997;48:346-351.
17. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736-743.
18. Blackburn H. Classification of the electrocardiogram for population studies: Minnesota Code. J Electrocardiol. 1969;2:305-310.
19. Allison P. Survival Analysis Using SAS: A Practical Guide. 2nd ed. Cary, NC: SAS Institute; 2010.
20. Thom T. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Heart Lung and Blood Institute; 2006.
21. Portnoy BA, Herion JC. Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med. 1972;76:643-652.
22. Lannuzel A, Salmon V, Mével G, Malpote E, Rabier R, Caparros-Lefebvre D. [Epidemiology of stroke in Guadeloupe and role of sickle cell trait]. Rev Neurol (Paris). 1999;155:351-356.
23. Bucknor MD, Goo JS, Coppolino ML. The risk of potential thromboembolic, renal and cardiac complications of sickle cell trait. Hemoglobin. 2014;38:28-32.
24. Strouse JJ, Lanzkron S, Urrutia V. The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol. 2011;4:597-606.
25. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: The excess burden of stroke among blacks. Stroke. 2004;35:426-431.
26. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317:781-787.
27. Martin TW, Weisman IM, Zeballos RJ, Stephenson SR. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait. Am J Med. 1989;87:48-56.
28. Singer ST, Ataga KI. Hypercoagulability in sickle cell disease and betathalassemia. Curr Mol Med. 2008;8:639-645.
29. Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, et al. Coagulation changes in individuals with sickle cell trait. Am J Hematol. 2002;69:89-94.
30. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sicklecell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979;300:1001-1005.
31. McCormick W. Abnormal Hemoglobins: II. The Pathology of Sickle Cell Trait. Am J Med Sci. 1961;241:329.
32. Steen RG, Hankins GM, Xiong X, Wang WC, Beil K, Langston JW, et al. Prospective brain imaging evaluation of children with sickle cell trait: initial observations. Radiology. 2003;228:208-215.
33. Ince B, Petty GW, Brown RD Jr, Chu CP, Sicks JD, Whisnant JP. Dolichoectasia of the intracranial arteries in patients with first ischemic stroke: A population-based study. Neurology. 1998;50:1694-1698.
34. Mosley TH Jr, Knopman DS, Catellier DJ, Bryan N, Hutchinson RG, Grothues CA, et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk in Communities study. Neurology. 2005;64:2056-2062.
35. Longstreth WT Jr, Arnold AM, Kuller LH, Bernick C, Lefkowitz DS, Beauchamp NJ Jr, et al. Progression of magnetic resonance imagingdefined brain vascular disease predicts vascular events in elderly: The Cardiovascular Health Study. Stroke. 2011;42:2970-2972.